What Arbutus ABUS subscription metrics reveal about retention Arbutus notches 44 EPS beat with narrower than expected loss How Inhibikase Therapeutics IKT is navigating logistics challenges Q4 2025 EPS Tops Views The debt management strategy at Boyd Group BGSI Q4 2025 Earnings Beat Estimates Fonterra Cooperative Group FCG HighYield Asian Dividend Play Balancing Attractive Income Against Sustainability Risks Why Nasus Pharma NSRX looks solid from every angle Investors Pile In 20260508 HSCSW HeartSciences quarterly results show strategic progress as innovation pipeline drives growth CEO upbeat on outlook What BioNTech BNTX segment performance reveals BioNTech posts narrower than expected loss beats EPS by 14 percent ESI Element Solutions Q1 earnings beat estimates but shares tumble 445 on outlook concerns